Assignment of Core versus Antenna Fucosylation Types in Protein N-Glycosylation via Procainamide Labeling and Tandem Mass Spectrometry.
暂无分享,去创建一个
Charles C Nwosu | Steven Becht | Hoi Kei Yau | S. Becht | Charles Nwosu | Hoi Kei Yau | Charles C. Nwosu
[1] Jun-Tao Ji,et al. Decreased Core-Fucosylation Contributes to Malignancy in Gastric Cancer , 2014, PloS one.
[2] Akira Okazaki,et al. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics. , 2007, Journal of biotechnology.
[3] Kazuya Yamano,et al. Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. , 2004, Biotechnology and bioengineering.
[4] B. Ernst,et al. False sugar sequence ions in electrospray tandem mass spectrometry of underivatized sialyl-Lewis-type oligosaccharides , 1997 .
[5] H. Matsumoto,et al. Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy , 2012, Biomolecules.
[6] K. Shitara,et al. Defucosylated Chimeric Anti-CC Chemokine Receptor 4 IgG1 with Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma , 2004, Cancer Research.
[7] F. Wold,et al. Effects of the protein matrix on glycan processing in glycoproteins , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] Shinji Hosoi,et al. Comparison of cell lines for stable production of fucose‐negative antibodies with enhanced ADCC , 2006, Biotechnology and bioengineering.
[9] D. Harvey. Collision-induced fragmentation of negative ions from N-linked glycans derivatized with 2-aminobenzoic acid. , 2005, Journal of mass spectrometry : JMS.
[10] Naoko Yamane-Ohnuki,et al. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region. , 2005, Journal of immunological methods.
[11] Angela M Zivkovic,et al. Simultaneous and extensive site-specific N- and O-glycosylation analysis in protein mixtures. , 2011, Journal of proteome research.
[12] J. Lowe. Glycosylation, Immunity, and Autoimmunity , 2001, Cell.
[13] R. Aster. Core fucosylation and IgG function in NAIT. , 2014, Blood.
[14] P. Emery,et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. , 2004, The New England journal of medicine.
[15] K. Shitara,et al. Enhancement of the Antibody-Dependent Cellular Cytotoxicity of Low-Fucose IgG1 Is Independent of FcγRIIIa Functional Polymorphism , 2004, Clinical Cancer Research.
[16] Masako Wakitani,et al. Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharides. , 2006, Journal of biochemistry.
[17] Shigeru Iida,et al. Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity , 2004, Biotechnology and bioengineering.
[18] S. Becht,et al. Glycosylation characterization of Human IgA1 with differential deglycosylation by UPLC-ESI TOF MS. , 2011, Journal of pharmaceutical and biomedical analysis.
[19] Akira Okazaki,et al. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. , 2007, Glycobiology.
[20] K. Shitara,et al. Enhanced Natural Killer Cell Binding and Activation by Low-Fucose IgG1 Antibody Results in Potent Antibody-Dependent Cellular Cytotoxicity Induction at Lower Antigen Density , 2005, Clinical Cancer Research.
[21] A. Helenius,et al. Intracellular functions of N-linked glycans. , 2001, Science.
[22] Masakazu Toi,et al. A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients , 2007, Clinical Cancer Research.
[23] Naoko Yamane-Ohnuki,et al. Production of therapeutic antibodies with controlled fucosylation , 2009, mAbs.
[24] M. Novotny,et al. Resolution of the branched forms of oligosaccharides by high-performance capillary electrophoresis. , 1994, Carbohydrate research.
[25] André M Deelder,et al. Mass spectrometry of proton adducts of fucosylated N-glycans: fucose transfer between antennae gives rise to misleading fragments. , 2006, Rapid communications in mass spectrometry : RCM.
[26] A. Dell,et al. Structural characterization of the N-glycans of Dictyocaulus viviparus: discovery of the Lewis(x) structure in a nematode. , 2000, Glycobiology.
[27] Shigeru Iida,et al. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. , 2005, Journal of immunological methods.
[28] R Apweiler,et al. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.
[29] Mary Ann Comunale,et al. Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma , 2009, Cancer Epidemiology Biomarkers & Prevention.
[30] P. Pilarski,et al. Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with Rituximab , 2008, Clinical medicine. Oncology.
[31] Hyun Joo An,et al. Determination of N-glycosylation sites and site heterogeneity in glycoproteins. , 2003, Analytical chemistry.
[32] Jian Zhang,et al. The evaluation of a novel approach for the profiling and identification of N-linked glycan with a procainamide tag by HPLC with fluorescent and mass spectrometric detection. , 2010, Journal of pharmaceutical and biomedical analysis.
[33] M. Betenbaugh,et al. N-glycan patterns of human transferrin produced in Trichoplusia ni insect cells: effects of mammalian galactosyltransferase. , 2000, Glycobiology.
[34] Naoko Yamane-Ohnuki,et al. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region. , 2006, Journal of biochemistry.
[35] M. Nakano,et al. Detailed structural features of glycan chains derived from alpha1-acid glycoproteins of several different animals: the presence of hypersialylated, O-acetylated sialic acids but not disialyl residues. , 2004, Glycobiology.
[36] J. Montreuil. Spatial conformation of glycans and glycoproteins , 1984, Biology of the cell.
[37] K. Olden,et al. Carbohydrate moieties of glycoproteins. A re-evaluation of their function. , 1982, Biochimica et biophysica acta.
[38] S. Iida,et al. Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. , 2007, Molecular immunology.
[39] A. Varki,et al. Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.
[40] S. Iida,et al. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies , 2006, Expert opinion on biological therapy.
[41] K. Shitara,et al. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.
[42] Kouhei Tsumoto,et al. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. , 2004, Journal of molecular biology.
[43] S. Iida,et al. Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa , 2006, Clinical Cancer Research.
[44] L. Presta,et al. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.